What is the share price of ANG Lifesciences India Ltd (ANG) today?
The share price of ANG as on 15th September 2026 is ₹36.45. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on ANG Lifesciences India Ltd (ANG) share?
The past returns of ANG Lifesciences India Ltd (ANG) share are- Past 1 week: 5.37%
- Past 1 month: 9.28%
- Past 3 months: 20.05%
- Past 6 months: 53.90%
- Past 1 year: 15.42%
- Past 3 years: -51.65%
- Past 5 years: -86.08%
What are the peers or stocks similar to ANG Lifesciences India Ltd (ANG)?
The peers or stocks similar to ANG Lifesciences India Ltd (ANG) include:What is the market cap of ANG Lifesciences India Ltd (ANG) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of ANG Lifesciences India Ltd (ANG) is ₹46.91 Cr as of 15th September 2026.What is the 52 week high and low of ANG Lifesciences India Ltd (ANG) share?
The 52-week high of ANG Lifesciences India Ltd (ANG) is ₹49.69 and the 52-week low is ₹17.63.What is the PE and PB ratio of ANG Lifesciences India Ltd (ANG) stock?
The P/E (price-to-earnings) ratio of ANG Lifesciences India Ltd (ANG) is -4.23. The P/B (price-to-book) ratio is 0.73.Which sector does ANG Lifesciences India Ltd (ANG) belong to?
ANG Lifesciences India Ltd (ANG) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy ANG Lifesciences India Ltd (ANG) shares?
You can directly buy ANG Lifesciences India Ltd (ANG) shares on Tickertape. Simply sign up, connect your demat account and place your order.
ANG Lifesciences India Ltd
ANG Share Price
BSE₹36.451.48% (+0.53)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
ANG Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
BadThe stock is in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
ANG Performance & Key Metrics
ANG Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -3.52 | 0.73 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 46.80 | 5.89 | 0.49% |
ANG Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
ANG Company Profile
ANG Lifesciences India is a pharmaceutical company, engaged in the business of manufacturing and marketing of finished pharmaceutical formulations in a dosage form of sterile dry powder injection vials
SUNPHARMA
PE Ratio
38.46
38.46
1Y Return
14.31%
14.31%
Buy Reco %
93.55
93.55
TORNTPHARM
PE Ratio
87.30
87.30
1Y Return
38.56%
38.56%
Buy Reco %
81.48
81.48
ZYDUSLIFE
PE Ratio
22.15
22.15
1Y Return
7.23%
7.23%
Buy Reco %
57.69
57.69
CIPLA
PE Ratio
28.45
28.45
1Y Return
12.48%
12.48%
Buy Reco %
62.86
62.86
LAURUSLABS
PE Ratio
119.70
119.70
1Y Return
119.85%
119.85%
Buy Reco %
58.33
58.33
ANG Forecast
ANG Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
ANG
ANG
Income
Balance Sheet
Cash Flow
Quarterly Normal View
ANG Income Statement
ANG Income Statement
Quarterly Normal View
| Quarter | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | jun 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 38.03 | 19.69 | 33.23 | 24.46 | 17.47 | 24.69 | 26.18 | 18.89 | 23.67 | 15.41 | ||||||||||
Operating & Other expenses | 36.22 | 20.12 | 30.60 | 26.88 | 17.52 | 23.96 | 25.97 | 21.42 | 20.83 | 17.25 | ||||||||||
EBITDA | 1.81 | -0.43 | 2.63 | -2.42 | -0.05 | 0.73 | 0.21 | -2.53 | 2.84 | -1.84 | ||||||||||
| Depreciation/Amortization | 2.05 | 1.63 | 1.74 | 1.96 | 1.42 | 1.53 | 1.52 | 1.51 | 1.77 | 1.50 | ||||||||||
| PBIT | -0.24 | -2.06 | 0.89 | -4.38 | -1.47 | -0.80 | -1.31 | -4.04 | 1.07 | -3.34 | ||||||||||
| Interest & Other Items | 3.84 | 2.08 | 2.18 | 2.00 | 2.42 | 1.94 | 1.89 | 1.93 | 2.18 | 2.24 | ||||||||||
| PBT | -4.08 | -4.14 | -1.29 | -6.38 | -3.89 | -2.74 | -3.20 | -5.97 | -1.11 | -5.58 | ||||||||||
| Taxes & Other Items | -0.43 | -1.07 | 0.80 | -1.19 | -1.83 | -0.73 | -0.27 | -1.21 | 0.28 | -1.34 | ||||||||||
| Net Income | -3.65 | -3.07 | -2.09 | -5.19 | -2.06 | -2.01 | -2.93 | -4.76 | -1.39 | -4.24 | ||||||||||
| EPS | -2.75 | -2.35 | -1.53 | -3.98 | -1.56 | -1.52 | -2.24 | -3.60 | -1.07 | -3.24 |
ANG Company Updates
ANG Stock Peers
ANG Past Performance & Peer Comparison
ANG Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| ANG Lifesciences India Ltd | -4.23 | 0.73 | — |
| Sun Pharmaceutical Industries Ltd | 38.46 | 5.26 | 0.87% |
| Torrent Pharmaceuticals Ltd | 87.30 | 10.74 | 0.68% |
| Zydus Lifesciences Ltd | 22.15 | 3.77 | 0.09% |
ANG Stock Price Comparison
Compare ANG with any stock or ETFCompare ANG with any stock or ETF
ANG
ANG Holdings
ANG Shareholdings
ANG Promoter Holdings Trend
ANG Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
High Pledged Promoter Holding
Lower pledged promoter holdings is considered better
A significant proportion of promoter holdings is pledged
ANG Institutional Holdings Trend
ANG Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
ANG Shareholding Pattern
ANG Shareholding Pattern
ANG Shareholding History
ANG Shareholding History
Foreign Institutions
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing ANG stock
smallcases containing ANG stock
Looks like this stock is not in any smallcase yet.
ANG Events
ANG Events
ANG Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
ANG Dividend Trend
No dividend trend available
ANG Upcoming Dividends
ANG Upcoming Dividends
No upcoming dividends are available
ANG Past Dividends
ANG Past Dividends
Cash Dividend
Ex DateEx DateNov 2, 2021
Interim
Interim | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Nov 2, 2021
ANG Stock News & Opinions
ANG Stock News & Opinions
Articles & Videos
Earnings
Earnings
ANG Lifesciences India reports consolidated net loss of Rs 1.38 crore in the March 2026 quarterNet Loss of ANG Lifesciences India reported to Rs 1.38 crore in the quarter ended March 2026 as against net loss of Rs 2.06 crore during the previous quarter ended March 2025. Sales rose 39.71% to Rs 23.50 crore in the quarter ended March 2026 as against Rs 16.82 crore during the previous quarter ended March 2025. For the full year,net loss reported to Rs 11.08 crore in the year ended March 2026 as against net loss of Rs 12.41 crore during the previous year ended March 2025. Sales rose 0.04% to Rs 92.89 crore in the year ended March 2026 as against Rs 92.85 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales23.5016.82 40 92.8992.85 0 OPM %11.36-4.16 -0.76-2.44 - PBDT0.67-2.47 LP -6.68-8.94 25 PBT-1.10-3.89 72 -13.01-15.70 17 NP-1.38-2.06 33 -11.08-12.41 11 Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Corporate
ANG Lifesciences India to convene board meetingANG Lifesciences India will hold a meeting of the Board of Directors of the Company on 30 May 2026.
3 months agoCapital Market - Live
Earnings
Earnings
ANG Lifesciences India reports consolidated net loss of Rs 4.75 crore in the December 2025 quarterNet Loss of ANG Lifesciences India reported to Rs 4.75 crore in the quarter ended December 2025 as against net loss of Rs 5.19 crore during the previous quarter ended December 2024. Sales declined 24.26% to Rs 18.73 crore in the quarter ended December 2025 as against Rs 24.73 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales18.7324.73 -24 OPM %-14.36-8.69 - PBDT-4.45-4.42 -1 PBT-5.96-6.38 7 NP-4.75-5.19 8 Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Corporate
ANG Lifesciences India to table resultsANG Lifesciences India will hold a meeting of the Board of Directors of the Company on 14 February 2026.Powered by Capital Market - Live
7 months agoCapital Market - Live
Earnings
Earnings
ANG Lifesciences India reports consolidated net loss of Rs 2.95 crore in the September 2025 quarterNet Loss of ANG Lifesciences India reported to Rs 2.95 crore in the quarter ended September 2025 as against net loss of Rs 2.09 crore during the previous quarter ended September 2024. Sales declined 20.77% to Rs 26.05 crore in the quarter ended September 2025 as against Rs 32.88 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales26.0532.88 -21 OPM %0.316.96 - PBDT-1.690.45 PL PBT-3.21-1.29 -149 NP-2.95-2.09 -41 Powered by Capital Market - Live
9 months agoCapital Market - Live
Corporate
Corporate
ANG Lifesciences India to conduct board meetingANG Lifesciences India will hold a meeting of the Board of Directors of the Company on 14 November 2025.Powered by Capital Market - Live
10 months agoCapital Market - Live
Corporate
Corporate
ANG Lifesciences India schedules AGMANG Lifesciences India announced that the Annual General Meeting(AGM) of the company will be held on 30 September 2025.Powered by Capital Market - Live
11 months agoCapital Market - Live
Earnings
Earnings
ANG Lifesciences India reports consolidated net loss of Rs 2.01 crore in the June 2025 quarterNet Loss of ANG Lifesciences India reported to Rs 2.01 crore in the quarter ended June 2025 as against net loss of Rs 3.07 crore during the previous quarter ended June 2024. Sales rose 33.62% to Rs 24.60 crore in the quarter ended June 2025 as against Rs 18.41 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales24.6018.41 34 OPM %2.60-9.23 - PBDT-1.20-2.51 52 PBT-2.73-4.14 34 NP-2.01-3.07 35 Powered by Capital Market - Live
1 year agoCapital Market - Live
Corporate
Corporate
ANG Lifesciences India to convene board meetingANG Lifesciences India will hold a meeting of the Board of Directors of the Company on 14 August 2025.Powered by Capital Market - Live
1 year agoCapital Market - Live
Earnings
Earnings
ANG Lifesciences India reports consolidated net loss of Rs 2.06 crore in the March 2025 quarterNet Loss of ANG Lifesciences India reported to Rs 2.06 crore in the quarter ended March 2025 as against net loss of Rs 3.65 crore during the previous quarter ended March 2024. Sales declined 55.55% to Rs 16.82 crore in the quarter ended March 2025 as against Rs 37.84 crore during the previous quarter ended March 2024. For the full year,net loss reported to Rs 12.41 crore in the year ended March 2025 as against net loss of Rs 10.14 crore during the previous year ended March 2024. Sales declined 36.45% to Rs 92.85 crore in the year ended March 2025 as against Rs 146.11 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales16.8237.84 -56 92.85146.11 -36 OPM %-4.168.88 --2.446.61 - PBDT-2.47-0.29 -752 -8.94-0.60 -1390 PBT-3.89-2.34 -66 -15.70-8.97 -75 NP-2.06-3.65 44 -12.41-10.14 -22 Powered by Capital Market - Live
1 year agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of -9.62%, vs industry avg of 11.78%
Over the last 5 years, market share decreased from 0.05% to 0.02%